EBV (BZLF1)
Online Inquiry
| CAT# | PPO-H012 |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Purity | >70% (HPLC-MS) |
| Areas of Interest | Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sj?gren's syndrome, Multiple sclerosis |
| Size | 1 vial containing 15 nmol ( 25μg) per peptide |
SwissProt ID | P03206 |
Format | Freeze dried in amber type glass vial |
NumberOfPeptides | 59 |
Organism | Epstein-Barr virus (HHV-4) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Protein Length | 245 |
Protein Name | Trans-activator protein BZLF1 |
References | 1."PepMixTM Peptide Pools for Clinical Applications: T cell therapy for viral infections after hematopoietic stem cell transplant"
Leen et al, Application Note (2012)
2."Expansion of T Cells Targeting Multiple Antigens of Cytomegalovirus, Epstein – Barr Virus and Adenovirus to Provide Broad Antiviral Specificity After Stem Cell Transplantation". Hanley et al., Cytotherapy (2011)
3."Rebound of Residual Plasma Viremia After Initial Decrease Following Addition of Intravenous Immunoglobulin to Effective Antiretroviral Treatment of HIV". Mellberg et al., AIDS Research and Therapy (2011)
4."A Whole Blood Monokine-based Reporter Assay Provides a Sensitive and Robust Measurement of the Antigen-Specific T Cell Response"
Chakera et al., Journal of Translational Medicine (2011)
5."Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma". Louis et al., J Immunother (2010)
6."Effective and Long-term Control of EBV PTLD After Transfer of Peptide-Selected T Cells". Moosmann et al., BLOOD (2010)
7."Accelerated Production of Antigen-Specific T-cells for Pre-Clinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)". Vera et al., J Immunother. (2010)
8."Derivation of Human T Lymphocytes From Cord Blood and Peripheral Blood with Antiviral and Antileukemic Specificity from a Single Culture as Protection Against Infection and Relapse after Stem Cell Transplantation". Micklethwaite et al., Blood (2010) |
Write a review
Ask a question
My Review for EBV (BZLF1)
Required fields are marked with *
×
Ask a Question for EBV (BZLF1)
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
